Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Gilead evaluates GS-6207 with other antiretrovirals for HIV in new phase II study

Dec. 24, 2019

FDA issues complete response letter for long-acting cabotegravir/rilpivirine regimen for HIV

Dec. 23, 2019

Merck & Co. patents HIV integrase inhibitors

Dec. 23, 2019

New HIV integrase inhibitors identified at Shionogi

Dec. 17, 2019

New long-acting HIV-1 fusion inhibitor-based regimen developed

Dec. 13, 2019

Improbability research yields path to HIV vaccine

Dec. 13, 2019

FDA clears IND application for first-in-human study of CPT-31

Dec. 11, 2019

World AIDS Day: Immediate ART initiation for neonates with HIV-1 provides significant benefits

Dec. 2, 2019

Less can be more for HIV vaccines, in several ways

Nov. 27, 2019

ViiV Healthcare synthesizes prodrugs of HIV maturation inhibitors

Nov. 15, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...